Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 5 years ago

Possible Interaction: Arachidonate and Masoprocol

supplement:

Arachidonate

supplement:

Masoprocol

Research Papers that Mention the Interaction

“ Nordihydroguarietic acid (6-12 X 10(-6) M) attenuated both the antigen plus arachidonate induced responses.”
Canadian journal of physiology and pharmacology  •  1983  |  View Paper
“When 20 microM nordihydroguayaretic acid , a selective inhibitor of arachidonate lypooxidation, was added to the incubation medium, DNA fragmentation was observed to be significantly less, especially at the early steps of incubation.”
Radiatsionnaia biologiia, radioecologiia  •  1999  |  View Paper
“When 20 mM nordihydroguaiaretic acid , a selective inhibitor of arachidonate lipooxidation, was added to the incubation medium, DNA fragmentation was observed to be significantly less, especially at the early steps of incubation.”
Ukrainskii biokhimicheskii zhurnal  •  1998  |  View Paper
“The lipoxygenase inhibitor nordihydroguaiaretic acid (NDGA) significantly reduced release of arachidonate ; however, levels of thromboxane and 12-HHT were significantly increased.”
Experimental lung research  •  1993  |  View Paper
“Inhibition of the general oxidative metabolism of arachidonate by 10(-5) M ETYA or of the arachidonate lipoxygenase metabolism by 10(-5) M NDGA decreased basal Prl release to 45 +/- 10% (n = 3) and 36 +/- 4% (n = 6) of the control release, respectively.”
Life sciences  •  1990  |  View Paper
“Three mixed cyclooxygenase/lipoxygenase inhibitors, BW755C, phenidone, and nordihydroguaiaretic acid , suppressed vascular response by 9%, 9%, and 6% for 150 nmol of AA , and by 9%, 13%, and 12% for 300 nmol of AA, respectively.”
The Journal of investigative dermatology  •  1989  |  View Paper
“4 Nordihydroguaiaretic acid (NDGA; 11 μm) markedly inhibited the contractile response of denuded strips to arachidonate.”
British journal of pharmacology  •  1987  |  View Paper
“The inhibitors of lipoxygenase activity, nordihydroguaiaretic acid and eicosatetraynoic acid, had direct effects on soluble guanylate cyclase and interfered with its activation by arachidonate , whereas another lipoxygenase inhibitor, BW 755 C, did not.”
Biochimica et biophysica acta  •  1986  |  View Paper